Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,785 | 0,800 | 19:10 | |
0,785 | 0,800 | 19:07 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
18.07. | NanoVibronix-Aktionäre geben grünes Licht für Aktienzusammenlegung | 11 | Investing.com Deutsch | ||
18.07. | NanoVibronix, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
18.07. | NanoVibronix enters into $50M financing agreement | 1 | MassDevice | ||
18.07. | NanoVibronix sichert sich Finanzierung über 8 Millionen US-Dollar mit Option auf Aufstockung | 1 | Investing.com Deutsch | ||
18.07. | NanoVibronix secures $8 million in funding, with potential for more | 1 | Investing.com | ||
11.07. | NanoVibronix vertagt außerordentliche Hauptversammlung mangels Beschlussfähigkeit | 4 | Investing.com Deutsch | ||
09.07. | NanoVibronix korrigiert Mindestpreis für Vorzugsaktien der Serie G | 2 | Investing.com Deutsch | ||
09.07. | NanoVibronix, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
NANOVIBRONIX Aktie jetzt für 0€ handeln | |||||
27.06. | Pre-market Movers: Blue Gold, INmune Bio, Cyngn, NanoVibronix, GlucoTrack | 713 | AFX News | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.20 A.M. ET).In the Green Blue Gold Limited (BGL) is up over 297% at $80.01.
INmune... ► Artikel lesen | |
26.06. | NanoVibronix has a next-gen robotic system under development | 20 | MassDevice | ||
11.06. | NanoVibronix erhält US-Patent für pädiatrisches Ernährungssondensystem | 16 | Investing.com Deutsch | ||
05.06. | NanoVibronix names new CEO | 3 | MassDevice | ||
04.06. | NanoVibronix, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
04.06. | NanoVibronix appoints new CEO after acquisition | 2 | Investing.com | ||
29.05. | Pre-market Movers: Zeo Energy, Elong Power, Brooge Energy, NanoVibronix, Polyrizon | 554 | AFX News | OVERLAND PARK (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.25 A.M. ET).In the Green Zeo Energy Corp. (ZEO) is up over 121% at... ► Artikel lesen | |
28.05. | NanoVibronix refutes false stock offering claims | 19 | Investing.com | ||
20.05. | NanoVibronix, Inc. - 10-Q, Quarterly Report | 15 | SEC Filings | ||
16.05. | NanoVibronix, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
15.05. | NanoVibronix announces pricing of $10 million public offering | 19 | Seeking Alpha | ||
15.05. | NanoVibronix sets terms for $10 million public offering | 22 | Investing.com |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 47,850 | -0,25 % | Ohne Wolfram kein Hightech - dieser Flaschenhals bringt Rendite: Almonty, Siemens Healthineers, Intel | Wolfram gilt aufgrund seiner Härte und Hitzebeständigkeit als Rüstungsmetall. Doch es ist auch einer der unsichtbaren Motoren der Hightech-Industrie. Wir erklären anhand von Beispielen aus der Medizintechnik... ► Artikel lesen | |
SERNOVA BIOTHERAPEUTICS | 0,121 | -3,97 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
BECTON DICKINSON | 159,30 | +0,92 % | BD (Becton, Dickinson and Company): BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas Wearable Injector Technology for Biologic Drugs | FRANKLIN LAKES, N.J., July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored... ► Artikel lesen | |
NUGEN MEDICAL DEVICES | 0,034 | -7,07 % | Beaking News: Vive la InsuJet - mit der Krankenkasse zum Erfolg? | ||
ATOSSA THERAPEUTICS | 0,700 | -1,27 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
SPINEWAY | 0,123 | +11,82 % | Spineway: GMED approval for new production line dedicated to ESP prostheses - First production of LP-ESP intervertebral disc prostheses | Press release Ecully, July 3, 2025 - 6:30 p.m. SPINEWAY GMED approval for new production line dedicated to ESP prostheses First production of LP-ESP intervertebral disc prostheses Spineway... ► Artikel lesen | |
PING AN HEALTHCARE | 1,110 | +3,35 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor Revamps Brand and Launches Annual Healthcare Service Brand | HONG KONG and SHANGHAI, June 11, 2025 /PRNewswire/ -- The Ping An Good Doctor Brand Revamp & Ping An Healthcare Services Brand Launch Conference was held in Shanghai. Ping An Healthcare and... ► Artikel lesen | |
MOUNTAIN VALLEY MD | 0,011 | -22,97 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
CO-DIAGNOSTICS | 0,250 | +5,04 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
CYTOSORBENTS | 0,840 | +4,09 % | A Glimpse Into The Expert Outlook On CytoSorbents Through 5 Analysts | ||
VERU | 0,475 | -0,88 % | VERU INC. - 8-K, Current Report | ||
LIFEWARD | 0,790 | +2,33 % | Lifeward Ltd.: Administrative Law Judge Determines ReWalk Personal Exoskeleton is "Reasonable and Necessary" for Medicare Beneficiary | MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 24, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China | Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest... ► Artikel lesen | |
VOLITIONRX | 0,749 | 0,00 % | VolitionRx - Nu.Q advances in lung cancer management | Despite rapid advancements in cancer treatments, effective diagnostics for early screening and disease monitoring continue to be an unmet need. This is felt acutely in lung cancer, which is the leading... ► Artikel lesen | |
EKSO BIONICS | 5,130 | +6,88 % | Preview: Ekso Bionics Holdings' Earnings |